Komori
Business alliance9341GENOVA,Inc.Information and Communications, Services and Others

(Notice) Rollout of the POCKETALK AI translation device to partner clinics nationwide

The Company will progressively introduce SOURCENEXT CORPORATION’s AI translation device “POCKETALK” at affiliated clinics nationwide and use it to provide multilingual support from reception through payment.

Worth reading
26Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
125
¥ billion (estimated potential domestic market size for AI translation devices for medical institutions)
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

9341GENOVA,Inc.
Alliance partnerSOURCENEXT CORPORATION
Details of the alliance
  1. 1

    Enable multilingual communication throughout the entire patient journey, from reception, medical interviews, and consultations through payment

  2. 2

    Introduce the AI translation device “POCKETALK” at affiliated clinics

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

Alliance start dateTo be rolled out progressively from 17 June 2026 onward (予定)
Agreements reached under this partnership
ItemDetails
Name of alliance partnerSOURCENEXT CORPORATION
Details of the allianceEnable multilingual communication throughout the entire patient journey, from reception, medical interviews, and consultations through payment, Introduce the AI translation device “POCKETALK” at affiliated clinics
Alliance start dateTo be rolled out progressively from 17 June 2026 onward (予定)
Items this document does not state (20)
Alliance partner's business activitiesAlliance partner's locationAlliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeType of allianceNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionContract DateShare Acquisition Date and Payment DateImpact on Business PerformanceChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The increase in foreign visitors to Japan and foreign residents has heightened the need for language support in medical settings, intensifying challenges in areas such as medical interviews, understanding patients’ symptoms, and explaining insurance information and self-funded medical services.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Notice) Rollout of the POCKETALK AI translation device to partner clinics nationwide | GENOVA,Inc. (9341) timely disclosure | Komori